We provide evidence in both mice and humans that the coordinated expression of CXCR3, CCR5, and CXCR6 defines distinct CD8+ T-cell subsets with divergent roles in mediating tumor clearance and immune-related toxicity following dual checkpoint blockade. The gene discussed is CCR5; the disease is neoplasm.